Butyrylcholinesterase is an acetylcholine-degrading enzyme involved in the memorization process, which is becoming an interesting target for the symptomatic treatment of Alzheimer's disease. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.